地西他滨联合CHG方案治疗中高危老年急性髓系白血病的临床效果(4)
[14]Santini V，Ossenkoppele GJ.Hypomethylating agents in the treatment of acute myeloid leukemia：A guide to optimal use.Critical Reviews in Oncology/Hematolog[J].Crit Rev Oncol Hematol，2019，140：1-7.
[15]Nieto M，Demolis P，Behanzin E，et al.The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia：Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use[J].Oncologist，2016，21(6)：692-700.
[16]He J，Xiu L，Porre PD，et al.Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia：results from a post hocanalysis of a randomized phase Ⅲ study[J].Leuk Lymphoma，2015，56(4)：1033-1042.
[17]Jabbour E，Ghanem H，Huang X，et al.Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents：an emerging entity with a poor prognosis[J].Clin Lymphoma Myeloma Leuk，2014，14(2)：93-97.
(收稿日期：2019-10-14 本文編辑：李二云), http://www.100md.com(闫朝奇 冷青 季征)
[15]Nieto M，Demolis P，Behanzin E，et al.The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia：Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use[J].Oncologist，2016，21(6)：692-700.
[16]He J，Xiu L，Porre PD，et al.Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia：results from a post hocanalysis of a randomized phase Ⅲ study[J].Leuk Lymphoma，2015，56(4)：1033-1042.
[17]Jabbour E，Ghanem H，Huang X，et al.Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents：an emerging entity with a poor prognosis[J].Clin Lymphoma Myeloma Leuk，2014，14(2)：93-97.
(收稿日期：2019-10-14 本文編辑：李二云), http://www.100md.com(闫朝奇 冷青 季征)